Skip to main content
FinSpry Logo
FinSpry
GMAB logo
GMAB
(NASDAQ)
Genmab A/S
$27.50-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Genmab A/S (GMAB) Stock Price & Financial Analysis

Genmab A/S Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$26.55 - $27.53
52-Week High$35.43
52-Week Low$17.24
Open$26.55
Volume1.08M
Average Volume (3M)1.08M
Market Cap17.24B
Shares Outstanding626.92M
P/E Ratio (TTM)15.12
Forward P/E15.46
Price to Sales (P/S)1.82
Price to Book (P/B)0.46
EV/EBITDA15.04
Revenue (TTM)9.38B
Net Income (TTM)1.13B
Free Cash Flow (TTM)2.67B
EPS (TTM)$1.68
Profit Margin12.03%
Operating Margin27.18%
Return on Equity (ROE)3.04%
Debt to Equity0.95
50-Day MA$29.12
200-Day MA$28.11
52-Week Change45.87%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Genmab A/S

What is the current stock price for GMAB?

As of the latest trading session, GMAB stock trades at $27.50. The 52-week range is $17.24–$35.43, with a day range of $26.55–$27.53.

What is the P/E ratio for GMAB?

Genmab A/S's trailing P/E ratio is 15.1, meaning investors pay $15.1 for every $1 of annual earnings. The forward P/E is 15.5, reflecting analyst expectations for future earnings. Genmab A/S operates in the Healthcare sector.

Does GMAB pay dividends?

Genmab A/S does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for GMAB?

Based on 6 analysts, the consensus for GMAB is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of GMAB?

Genmab A/S's market capitalization is $17.24B, classifying it as a large-cap company. Genmab A/S operates in the Healthcare sector within the Biotechnology industry.